Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults - A Clinical Research Center study

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 8, 1996, Pages 2874-2880

  Chapman, Ian M ^a   Hartman, Mark L ^a   Pezzoli, Suzan S ^a   Thorner, Michael O ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 3 METHYL N [2,3,4,5 TETRAHYDRO 2 OXO 1 [[2' (1H TETRAZOL 5 YL) 1,1' BIPHENYL 4 YL]METHYL] 1H 1 BENZAZEPIN 3 YL]BUTANAMIDE; FOLLITROPIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; LUTEINIZING HORMONE; PROLACTIN; SERMORELIN; SOMATOMEDIN C; TESTOSTERONE;

ADULT; AGED; AGING; ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PULSATILE HORMONE RELEASE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

AGED; AGED, 80 AND OVER; BENZAZEPINES; FEMALE; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; INFUSION PUMPS; INFUSIONS, INTRAVENOUS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PULSATILE FLOW; REFERENCE VALUES; TETRAZOLES; TIME FACTORS;

EID: 0029809414     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.8.2874     Document Type: Article

References (44)

1. Thorner MO, Vance ML, Horvath E, Kovacs K. 1991 The anterior pituitary. In: Wilson JD, Foster DW, eds. Williams' textbook of endocrinology, 7th ed. Philadelphia: Saunders; 221-310.
2. Ho KY, Evans WS, Blizzard RM, et al. 1987 Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab. 64:51-58.
3. Zadik Z, Chalew SA, McCarter Jr RJ, Meistas M, Kowarski AA. 1985 The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab. 60:513-516.
4. Iranmanesh A, Lizzarralde G, Veldhuis JD. 1991 Age and relative adiposity are specific determinants of the frequency and amplitude of GH secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 73:1081-1088.
5. Corpas E, Harman SM, Blackman MR. 1993 Human growth hormone and human aging. Endocr Rev. 14:20-39.
6. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KKY. 1994 Diagnosis of growth-hormone deficiency in adults. Lancet. 343:1064-1068.
7. Thorner MO, Bengtsson BA, Ho KY, et al. 1995 The diagnosis of growth hormone deficiency (GHD) in adults [Letter]. J Clin Endocrinol Metab. 80:3097-3098.
8. Rudman D. 1985 Growth hormone, body composition, and aging [Review]. J Am Geriatr Soc. 33:800-807.
9. Rudman D, Feller AG, Nagraj HS, et al. 1990 Effects of human growth hormone in men over 60 years old. N Engl J Med. 323:1-6.
10. Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R. 1994 Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J Clin Endocrinol Metab. 79:470-479.
11. Taaffe DR, Pruitt L, Reim J, et al. 1994 Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. J Clin Endocrinol Metab. 79:1361-1366.
12. Yarasheski KE, Zachwieja JJ, Campbell JA, Bier DM. 1995 Effect of growth hormone and resistance exercise on muscle growth and strength in older men. Am J Physiol. 268:E268-E276.
13. Rosen T, Eden S, Larson G, Wilhelmsen L, Bengtsson BA. 1993 Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh). 129:195-200.
14. de Boer H, Blok GJ, Voerman HJ, Phillips M, Schouten JA. 1994 Serum lipid levels in growth hormone-deficient men. Metabolism. 43:199-203.
15. Salomon F, Cuneo RC, Heap R, Sonksen PH. 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 321:1797-1803.
16. Russell-Jones DL, Watts GF, Weissgberger A, et al. 1994 The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. Clin Endocrinol (Oxf), 41:345-350.
17. Rosen T, Bengtsson BA. 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 336:285-288.
18. Corpas E, Harman SM, Pineyro MA, Roberson R, Blackman MR. 1993 Continuous subcutaneous infusions of growth hormone (GH) releasing hormone 1-44 for 14 days increase GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 76:134-138.
19. Corpas E, Harman SM, Pineyro MA, Roberson R, Blackman MR. 1992 GHRH 1-29 twice daily reverses the decreased GH and IGF-I levels in old men. J Clin Endocrinol Metab. 75:530-535.
20. Bowers CY, Momany FA, Reynolds GA, Hong A. 1984 On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 114:1537-1545.
21. Ilson BE, Jorkasky DK, Curnow RT, Stote RM. 1989 Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects. J Clin Endocrinol Metab. 69:212-214.
22. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner MO. 1990 Growth Hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab. 70:975-982.
23. Bowers CY, Sartor AO, Reynolds GA, Badger TM. 1991 On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology. 128: 2027-2035.
24. Bowers CY, Alster DK, Frentz JM. 1992 The growth hormone-releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration. J Clin Endocrinol Metab. 74:292-298.
25. Hartman ML, Farello G, Pezzoli SS, Thorner MO. 1992 Oral administration of growth hormone (GH)-releasing peptide (GHRP) stimulates GH secretion in normal men. J Clin Endocrinol Metab. 74:1378-1384.
26. DeBell WK, Pezzoli SS, Thorner MO. 1991 Growth hormone secretion during continuous infusion of growth hormone releasing peptide (GHRP): partial response attenuation. J Clin Endocrinol Metab. 72:1312-1316.
27. Huhn WC, Hartman ML, Pezzoli SS, Thorner MO. 1993 24-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus. J Clin Endocrinol Metab. 76:1202-1208.
28. Smith RG, Cheng K, Schoen WR, et al. 1993 A nonpeptidyl growth hormone secretagogue. Science. 260:1640-1643.
29. Aloi JA, Gertz BJ, Hartman ML, et al. 1994 Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects. J Clin Endocrinol Metab. 79:943-949.
30. Gertz BJ, Barrett JS, Eisenhandler R, et al. 1993 Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone releasing peptide (GHRP-6). J Clin Endocrinol Metab. 77:1393-1397.
31. Chapman IM, Hartman ML, Straume M, Johnson ML, Veldhuis JD, Thorner MO. 1994 Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. J Clin Endocrinol Metab. 78:1312-1319.
32. Veldhuis JD, Liem AY, South S, et al. 1995 Differential impact of age, sexsteroid hormones, and obesity on basal vs. pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab. 80:3209-3222.
33. Iranmanesh A, Grisso B, Veldhuis JD. 1994 Low basal and persistent pulsatile growth hormone secretion are revealed in normal and hyposomatotropic men studied with a new ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab. 78:526-535.
34. Hartman ML, Veldhuis JD, Johnson ML, et al. 1992 Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two day fast in normal men. J Clin Endocrinol Metab. 74:757-765.
35. Johnson ML, Veldhuis JD. 1995 Evolution of deconvolution analysis as a hormone pulse detection method. Methods Neurosci. 28:1-24.
36. Veldhuis JD, Carlson ML, Johnson ML. 1987 The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proc Natl Acad Sci USA. 84:7686-7690.
37. Pong SS, Chaung LYP, Dean DC, Nargund RP, Patchett AA, Smith RG. 1996 Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol Endocrinol. 10:57-61.
38. Lieberman SA, Mitchell AM, Marcus R, Hintz RL, Huffman AR. 1994 The insulin-like growth factor I generation test: resistance to growth hormone with aging and estrogen replacement therapy. Horm Metab Res. 26:229-233.
39. Koch BD, Blalock JB, Schonbrunn A. 1988 Characterization of the cyclic AMP-independent actions of somatostatin in GH cells. I. An increase in potassium conductance is responsible for both the hyperpolarization and the decrease in intracellular free calcium produced by somatostatin. J Biol Chem. 263:216-225.
40. Ackman MS, Girard M, O'Brien LF, Ho AK, Chik CL. 1993 Mechanisms of action of a second generation growth hormone releasing peptide in rat anterior pituitary cells. Endocrinology. 132:1286-1291.
41. Goth MI, Lyons CE, Canny BJ, Thomer MO. 1992 Pituitary adenylate cyclase activating polypeptide, GH-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology. 130:939-944.
42. Dickson SL, Leng G, Dyball REJ, Smith RG. 1995 Central actions of peptide and non-peptide growth hormone secretagogues in the rat. Neuroendocrinology. 61:36-43.
43. Hartman ML, Faria ACS, Vance ML, Johnson ML, Thorner MO, Veldhuis JD. 1991 Temporal structure of in vivo growth hormone secretory events in man. Am J Physiol. 260:E101-E110.
44. Hartman ML, Iranmanesh A, Thorner MO, Veldhuis JD. 1993 Evaluation of pulsatile patterns of growth hormone release in humans: a brief review. Am J Hum Biol. 5:603-614.